Literature DB >> 28089909

Immunosuppression via Loss of IL2rγ Enhances Long-Term Functional Integration of hESC-Derived Photoreceptors in the Mouse Retina.

Jie Zhu1, Helen Cifuentes1, Joseph Reynolds1, Deepak A Lamba2.   

Abstract

Loss of photoreceptors is a common endpoint in degenerative retinal diseases. Human pluripotent stem cells provide a potential source for photoreceptor replacement, but, even in mouse models, the efficiency and efficacy of transplantation-based repair remains poor. In this study, we examined the degree to which immune rejection contributes to these disappointing outcomes using an immunodeficient IL2 receptor γ (IL2rγ)-null mouse model. Our results show that prevention of cell rejection in the normal and degenerating retinal environment significantly improves long-term survival and integration of hESC-derived donor retinal cells. Transplanted cells are able to differentiate into mature photoreceptors expressing various opsins and can functionally integrate into congenitally blind mice. Our work suggests that even though the retina is often considered immune-privileged, suppression of host immune-mediated cell rejection may well be a useful approach for improving long-term integration of transplanted cells with a view to successful clinical outcomes.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AMD; Leber congenital amaurosis; c-Fos; iPSC; immune rejection; natural killer cells; pupillary light reflex; retinitis pigmentosa; stem cells; visual function

Mesh:

Substances:

Year:  2017        PMID: 28089909     DOI: 10.1016/j.stem.2016.11.019

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  34 in total

1.  A new immunodeficient retinal dystrophic rat model for transplantation studies using human-derived cells.

Authors:  Biju B Thomas; Danhong Zhu; Tai-Chi Lin; Young Chang Kim; Magdalene J Seiler; Juan Carlos Martinez-Camarillo; Bin Lin; Yousuf Shad; David R Hinton; Mark S Humayun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-09-13       Impact factor: 3.117

2.  Reproducibility and staging of 3D human retinal organoids across multiple pluripotent stem cell lines.

Authors:  Elizabeth E Capowski; Kayvan Samimi; Steven J Mayerl; M Joseph Phillips; Isabel Pinilla; Sara E Howden; Jishnu Saha; Alex D Jansen; Kimberly L Edwards; Lindsey D Jager; Katherine Barlow; Rasa Valiauga; Zachary Erlichman; Anna Hagstrom; Divya Sinha; Valentin M Sluch; Xitiz Chamling; Donald J Zack; Melissa C Skala; David M Gamm
Journal:  Development       Date:  2019-01-09       Impact factor: 6.868

3.  hESC-derived photoreceptors survive and integrate better in immunodeficient retina.

Authors:  Magdalene J Seiler
Journal:  Stem Cell Investig       Date:  2017-08-23

4.  The Role of FGF9 in the Production of Neural Retina and RPE in a Pluripotent Stem Cell Model of Early Human Retinal Development.

Authors:  David M Gamm; Eric Clark; Elizabeth E Capowski; Ruchira Singh
Journal:  Am J Ophthalmol       Date:  2019-05-10       Impact factor: 5.258

5.  MANF delivery improves retinal homeostasis and cell replacement therapies in ageing mice.

Authors:  Joana Neves; Kathleen R Chirco; Wendy Cedron-Craft; Shereen Chew; Jie Zhu; Heinrich Jasper; Deepak A Lamba
Journal:  Exp Gerontol       Date:  2020-02-28       Impact factor: 4.032

6.  Cone fusion confusion in photoreceptor transplantation.

Authors:  Robert E MacLaren
Journal:  Stem Cell Investig       Date:  2017-08-29

Review 7.  Development of Stem Cell Therapies for Retinal Degeneration.

Authors:  Emma L West; Joana Ribeiro; Robin R Ali
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-08-03       Impact factor: 9.708

8.  Small Molecule-Based Retinal Differentiation of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells.

Authors:  Jie Zhu; Deepak A Lamba
Journal:  Bio Protoc       Date:  2018-06-20

Review 9.  Pluripotent Stem Cell-Based Organoid Technologies for Developing Next-Generation Vision Restoration Therapies of Blindness.

Authors:  Ratnesh K Singh; Francois Binette; Magdalene Seiler; Simon M Petersen-Jones; Igor O Nasonkin
Journal:  J Ocul Pharmacol Ther       Date:  2020-10-14       Impact factor: 2.671

10.  Pharmacologic fibroblast reprogramming into photoreceptors restores vision.

Authors:  Koray Dogan Kaya; Yan Fan; Biraj Mahato; Nathalie Sumien; Ritu A Shetty; Wei Zhang; Delaney Davis; Thomas Mock; Subrata Batabyal; Aiguo Ni; Samarendra Mohanty; Zongchao Han; Rafal Farjo; Michael J Forster; Anand Swaroop; Sai H Chavala
Journal:  Nature       Date:  2020-04-15       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.